When a patient with depression is feeling sleepy, be aware of sleep apnoea by Wiersema, Carlijn et al.
  
 University of Groningen
When a patient with depression is feeling sleepy, be aware of sleep apnoea





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2018
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Wiersema, C., Van Zelst, W., & Oude Voshaar, R. (2018). When a patient with depression is feeling sleepy,
be aware of sleep apnoea. BMJ Case Reports, 11. https://doi.org/10.1136/bcr-2018-224873
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 13-11-2019
1Wiersema C, et al. BMJ Case Rep 2018. doi:10.1136/bcr-2018-224873
Case report
When a patient with depression is feeling sleepy, be 
aware of sleep apnoea
Carlijn Wiersema, Willeke Van Zelst, richard oude Voshaar
Reminder of important clinical lesson
To cite: Wiersema C, 
Van Zelst W, oude Voshaar r. 
BMJ Case Rep published 
online First: [please 
include Day Month Year]. 
doi:10.1136/bcr-2018-
224873
University Center for psychiatry, 
University Medical Center 




 c. wiersema@ umcg. nl
accepted 18 June 2018
© BMJ publishing Group 
Limited 2018. re-use 
permitted under CC BY-NC. No 
commercial re-use. see rights 
and permissions. published 
by BMJ.
Summary
a 67-year-old man was referred to an outpatient clinic 
of geriatric psychiatry because of persistent symptoms 
of depression and anxiety, accompanied by sleepiness. 
the latter had been evaluated multiple times in the 
general practice over several years; each time it was 
considered to be a symptom of depression. after referral, 
the patient was diagnosed with severe obstructive sleep 
apnoea (osa), comorbid to a depressive and anxiety 
disorder. retrospectively, we conclude that affective 
symptoms accompanying osa and sleepiness were 
wrongfully interpreted as depression, but after having 
led to problems at work, they have triggered psychiatric 
comorbidity. treatment of osa in addition to the 
psychiatric disorders resulted in a full recovery over time. 
the delayed diagnosis of osa has certainly diminished 
the patient’s quality of life and might have precipitated 
the depressive disorder. Moreover, osa poses patients at 
an increased risk of cardiovascular disease, hypertension, 
stroke and traffic accidents.
BaCkground 
Obstructive sleep apnoea (OSA) is the most common 
sleep disorder worldwide, affecting 2%–6% of the 
adult population, increasing up to 15%–26% in 
those aged 70–100 years old.1 OSA is characterised 
by repetitive complete (apnoea) and partial (hypo-
pnoea) obstruction of the upper airway during 
sleep, which decreases arterial oxygen saturation.2 
Daytime functioning may be impaired due to loss 
of energy, depressed mood, irritability and concen-
tration difficulties, which are core symptoms of 
affective disorders. Therefore, the diagnosis of OSA 
may easily be missed in patients with depression. 
Moreover, sleepiness itself is one of the Diagnostic 
and Statistical Manual of Mental Disorders, fifth 
edition (DSM-5) criteria of depressive disorder and 
also overlaps with the criterion of fatigue or loss 
of energy.1 These diagnostic complexities may delay 
proper diagnosis of OSA in patients with depres-
sion. The aim of this case report is to increase 
awareness of the possibility of OSA in patients with 
depression.
CaSe preSenTaTion
A 67-year-old man was referred to our outpatient 
clinic of geriatric psychiatry because of persistent 
affective symptoms for years. The onset of symp-
toms coincided with an unpleasant work situation 
that, after a year of sick leave, had led to demo-
tion at 49 years of age. From that moment on, he 
suffered from depressed mood, anhedonia, loss 
of initiative, increased appetite, worrying, cata-
strophising, feelings of anxiety with excessive 
sweating, difficulties staying asleep, nightmares, 
increased need of sleep, loss of energy and tired-
ness. Symptoms fluctuated over the years but 
increased during autumn/winter, after life events 
and during vacation periods. Over the years, he 
had gradually withdrawn from social activities.
His general practitioner (GP) had prescribed 
benzodiazepine hypnotics, but without any 
improvement of symptoms. Six weeks prior to his 
referral, he was started on citalopram 20 mg one 
time a day, a first-line serotonergic antidepressant. 
He had lost 7 kg bodyweight due to nausea. This 
weight loss increased his physical fitness, which 
made him feel slightly better.
His medical history did not reveal other mental 
or physical symptoms.
The patient was monitored, but not treated, 
for mild hypertension by his GP. He had no 
other previous medical or psychiatric history. His 
family history revealed no psychiatric problems or 
neurodegenerative diseases like M. Parkinson, M. 
Alzheimer or M. Huntington. The patient did not 
smoke or drink alcohol. Besides citalopram, the 
patient used simvastatin 40 mg one time a day.
Heteroanamnestic information of his wife and 
son revealed a change in character since the onset 
of his symptoms; he became more emotional and 
insecure about himself. Since his retirement, he 
tended to lose his temper over seemingly insig-
nificant events. His wife explained that they slept 
apart for years because of his snoring. She neverthe-
less confirmed that his breathing paused regularly 
during sleep. Although they consulted their GP 
several times for his conspicuous sleepiness, they 
accepted the explanation that it was an inevitable 
part of his depression.
At psychiatric examination, we saw a tired man 
with bags under his eyes and reduced facial expres-
sion. Higher cognitive functions were intact. He 
had a depressed mood and flat affect, but denied 
suicidal ideation. Evaluation of his sleep pattern 
revealed a rapid sleep onset, but strikingly, he never 
woke up well rested, regularly dozed off during the 
day and he was often at risk of falling asleep while 
driving his car.
A full physical and neurological examination was 
remarkable only for an overweight body mass index 
(28.9 kg/m2) and hypertension (130/100 mm Hg). 
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inveSTigaTionS
In his next visits to our clinic, the patient repeatedly brought 
forward his work situation as being a traumatic event. This made 
him anxious in situations where he did not feel in control, like 
during his children’s holiday. He did not meet DSM-5 criteria 
of post-traumatic stress disorder, but he met the criteria for a 
depressive disorder, partly seasonal, with a superimposed gener-
alised anxiety disorder.
The patient scored 38 points on the 30-item Inventory of 
Depressive Symptomatology (IDS), which is indicative of a severe 
depression. The scores on the Mini-Mental State Exam (MMSE) 
and the Cambridge Examination for Mental Disorders of the 
Elderly/Cambridge Cognition test (CAMDEX/CAMCOG) were 
not indicative of cognitive problems (MMSE: 30/30, CAMDEX/
CAMCOG 90/120). Based on his wife’s information, he was 
additionally referred to a sleep clinic at our hospital. The score 
on the Epworth Sleepiness Scale was 16/24, which is indicative 
of excessive daytime sleepiness. Polysomnography showed 356 
apnoeas in 6 hours of sleep and an Apnoea–Hypopnoea Index 
(AHI) of 57. The arterial oxygen saturation varied between 76% 
and 95%. The sleep architecture was distorted, as no slow wave 
sleep was present. No significant periodic leg movements or 
other unusual movements were observed. The patient was diag-
nosed with severe OSA.
differenTial diagnoSiS
depressive disorder
Depressed mood, anhedonia, increased appetite, constant 
worrying, loss of initiative, withdrawal of social activities, 
sleeping problems, loss of energy, increasing symptoms during 
autumn/wintertime and lesser facial expression.
anxiety disorder
Feelings of anxiety with excessive sweating, catastrophising, 
nightmares, withdrawal of social situations and constant 
worrying.
post-traumatic stress disorder 
As a result of the unpleasant work situation, social withdrawal, 
nightmares and feelings of anxiety with excessive sweating.
neurodegenerative disease
Change in character, mood disruptions and temper issues.
obstructive sleep apnoea 
Severe loss of energy/tiredness, falling asleep while driving, 
dozing off during daytime, wake up not fully rested, snoring, 
breathing pauses during sleep, irritability, change of character, 
obesity and hypertension.
TreaTmenT
Citalopram, indicated for depressive as well as anxiety disor-
ders, slightly improved his depressed mood and reduced anxiety 
symptoms over the course of 8 weeks. The patient accepted 
cognitive–behavioural therapy (CBT), to improve coping with 
his work situation and to increase his self-esteem. Four weeks 
after starting CBT, the patient started with continuous positive 
airway pressure (CPAP) at night to treat his OSA.
ouTCome and follow-up
Since starting citalopram, the patient experienced a small 
improvement of his affective symptoms. With CBT, his self-image 
became more positive. Over the course of 3 months, prior to the 
start of CPAP, his affective symptoms further improved, without 
any effect on his sleep (related) problems and fatigue. After 
four nights of CPAP treatment, the patient felt more energetic 
and started rebuilding his life. Full recovery was achieved after 
4 months of treatment. His IDS score decreased from 38 to 8 (no 
depression present).
diSCuSSion
Although (hetero)anamnestic information may point to OSA, 
assessing the AHI by polysomnography is the gold standard 
for proper diagnosis. The AHI is the number of apnoeas or 
hypopnoeas recorded per hour of sleep. An AHI of 5–14 per 
hour indicates a mild, 15–30 a moderate and ≥30 a severe 
OSA. Hypopnoeas and apnoeas interrupt deep sleep and Rapid 
Eye Movement (REM) sleep and cause a fragmented sleeping 
pattern.2 Patients wake up feeling unrefreshed and they stay tired 
during the day. Night-time symptoms include snoring, breathing 
pauses, a feeling of choking, excessive salivation, excessive 
sweating, gastro-oesophageal reflux, nocturia, waking up with 
a dry mouth and/or a headache.1 3 During the day, the patient 
experiences excessive sleepiness, loss of energy, irritability,4 with-
drawal of social activities, difficulties with concentrating,5 cogni-
tive dysfunction,6 7 loss of interest in daily activities,8 temper 
issues,5 psychomotor changes4–8 and anxiousness and depressed 
mood.9 These symptoms bear a striking resemblance to symp-
toms of depression.3 10 11 Indeed, up to 63% of patients with 
OSA report depressive symptoms.9 11 12 Most sleep clinics there-
fore regularly evaluate depressive symptoms of their patients 
with screening questionnaires.3 The similarity in phenotypic 
expression of OSA and depressive disorders might be enough to 
misdiagnose sleep apnoea for a depressive disorder and wrong-
fully start antidepressant treatment.13 14 In our case, the affective 
symptoms accompanying OSA have been wrongfully attributed 
to a depression by his GP and even temporarily treated with 
benzodiazepines. When his work problems due to OSA triggered 
a full-blown depressive disorder, he was referred for specialised 
mental healthcare.
Of particular interest for this case is that depressive disorders 
and sleep disorders co-occur more often than can be expected by 
chance.15 16 This association is considered to be bidirectional as 
depression can evoke sleep disturbances and vice versa. Overall, 
90% of patients with depression experience sleep disturbances. 
Also, sleep apnoea is found more often in patients primarily 
diagnosed with depressive disorders compared with the general 
population.3 4 17–22 Because sleep disturbances are common in 
mood disorders, further examination is rarely employed.3 17 
Several authors have advocated screening for OSA in psychiatric 
patients, as this will hasten appropriate diagnosis.5 17 19 22–26 Treat-
ment of OSA will alleviate hypopnoeas and apnoeas and may 
improve affective symptoms.18 23 27–32 Especially in patients with 
therapy-resistant depression and/or patients with risk factors for 
OSA like male sex, obesity and older age, OSA must be consid-
ered.17 19 23 Our patient noticed some improvement after starting 
on citalopram, losing 7 kg of bodyweight and starting CBT, but 
the most significant improvement was following start of CPAP 
therapy.
Aside from improving psychiatric symptoms, the treat-
ment of OSA offers other health benefits by reducing the risk 
of cardiovascular disease33–35 and neurological damage.36 37 
The hypertension our patient presented with might be related 
to his OSA. Untreated OSA is associated with a twofold to 
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sleepiness.38 39 Our patient also described almost falling asleep 
while driving his car. Ascribing symptoms of OSA to a psychiatric 
disorder may result in inappropriate prescriptions of benzodiaz-
epines, as was the case in our patient. Whereas benzodiazepines 
are regularly used for treatment of anxiety and sleep(related) 
problems, benzodiazepines worsen hypopnoeas and apnoeas,24 
which can be life threatening for a patient with OSA. Apart from 
depression, our patient also suffered from an anxiety disorder. 
For this patient, it is quite possible that the anxiety was exacer-
bated by the OSA, as anxiety disorders are also associated with 
OSA.30 40 Moreover, daytime tiredness and anxiety are positively 
correlated in patients with OSA.41 CPAP treatment also has a 
positive effect on anxiety,32 as our patient experienced.
With this case report, we underline the importance of diag-
nosing and treating OSA in patients with a depressive disorder, 
even when the depression is preceded by psychosocial stressors. 
As illustrated by our patient, proper diagnostics may improve 
quality of life and prevent misdiagnosing affective symptoms as 
a treatment-resistant depression.
patient’s perspective
“The whole thing has actually been a positive experience for 
me, the discovery of the sleep apnoea has changed my life for 
the better. In hindsight I already had sleep problems and loss of 
energy for years, before the start of my depressive symptoms. 
I did not want to complain so I tried to live with it. I am very 
happy the doctors discovered my sleep apnoea, although it 
wasn’t what I expected when my general practitioner referred 
me to the psychiatric clinic! The medication and CBT really 
helped me, but the CPAP completed it. I am well now. I have 
my moments of feeling a little bit low, but that’s only around 
the fall/wintertime and is always of short duration. I think that’s 
just part of who I am. It has been never as bad as at that time. I 
realise how important it is to be healthy; the impact of the sleep 
apnoea, my depression and anxiety has been immense. But now 
I have my life back. I hope that physicians will learn from my 
case and will think of sleep apnoea as a cause of depression at 
an earlier stage.”
learning points
 ► The similarity between daytime symptoms of obstructive 
sleep apnoea and depressive disorders presents a diagnostic 
challenge.
 ► It is important to be vigilant regarding symptoms of excessive 
daytime sleepiness and risk factors of obstructive sleep 
apnoea in patients with depressive disorder.
 ► Good history taking of snoring, breathing pauses during 
sleep, waking up unrefreshed (sometimes with dry mouth 
and headaches) as well as a thorough physical examination 
(obesity, hypertension and crowded oropharynx) can point in 
the direction of obstructive sleep apnoea.
 ► Treatment of obstructive sleep apnoea should complement 
psychiatric or psychological treatment of depression to 
optimise quality of life, as well as physical health.
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